Skip to main content

Innovex International, Inc.

For the period ended Jun 30, 2026. Filed Aug 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 4, 2026

INVX$25.13+2.9%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets

(in thousands, except share and par value amounts)June 30,2026December 31,2025
Assets
Current assets
Cash and restricted cash$222,055$203,407
Trade receivables, net of allowance of $15,174 and $19,752 at June 30, 2026 and December 31, 2025, respectively240,094237,774
Contract assets3,2592,705
Inventories264,837248,433
Prepaid expenses and other current assets58,28235,728
Total current assets788,527728,047
Noncurrent assets
Property and equipment, net169,636158,874
Right-of-use assets – operating48,72852,204
Goodwill106,00599,720
Intangibles, net115,326116,230
Deferred tax asset, net89,341102,375
Other long-term assets10,18410,857
Total noncurrent assets539,220540,260
Total assets$1,327,747$1,268,307
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$77,188$60,711
Accrued expenses37,75549,148
Operating lease liabilities12,74112,670
Contract liabilities14,48411,986
Current portion of long-term debt and finance lease obligations6,0436,709
Other current liabilities9,3046,940
Total current liabilities157,515148,164
Noncurrent liabilities
Long-term debt and finance lease obligations19,04118,922
Operating lease liabilities36,72940,986
Deferred income taxes621500
Legal settlement accrual51,607—
Other long-term liabilities3,7352,036
Total noncurrent liabilities111,73362,444
Total liabilities$269,248$210,608
Commitments and contingencies (Note 16)
Stockholders’ equity
Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued)$—$—
Common stock: $0.01 par value, 200,000,000 shares authorized at June 30, 2026 and December 31, 2025; 68,875,856 and 69,077,237 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively689691
Additional paid-in capital772,905767,650
Accumulated other comprehensive income5,3944,084
Retained earnings279,511285,274
Total stockholders’ equity$1,058,499$1,057,699
Total liabilities and stockholders’ equity$1,327,747$1,268,307
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.